INTRODUCTION
Boron Neutron Capture Therapy (BNCT) is an experimental radiotherapy technique wherein boron carrier is administered in the patient's blood stream, the boron ( 10 B) atoms accumulate in the tumour cells and are irradiated with neutrons. The main therapeutic effect of BNCT is based on the neutron capture reaction 10 B(n,α) 7 Li. The lithium recoil and alpha particles have path lengths of a few micrometers in tissue restricting the high linear energy transfer exclusively in the boron containing cells. 1, 2) The boron dose contributes approximately half or more to the effective healthy tissue dose within the irradiated region in the patient.
In the Finnish BNCT project, L-p-boronophenylalanine (BPA) is used as the 10 B-carrier. Due to the low solubility of BPA at physiological pH, fructose complex of BPA (BPA-F) is used in the intravenous infusion. [3] [4] [5] Typically BPA-F infusions of 290-450 mg BPA/kg of body weight are used. In order to estimate reliably the blood boron concentration during the neutron irradiation, the patient blood samples are taken at regular intervals, before, during and after the BPA-F infusion. The boron concentration in the tumour and healthy tissues are estimated based on the tissue-to-blood concentration ratios related to the time-frame of the irradiation. 6) Fructose has been found to formulate the strongest and the most stable complex with BPA of the studied cis-diol monosaccharides.
7) The solubility of BPA as BPA-F is about 100 g/l. For fructose, boronate formation is likely with the anomeric hydroxyl at carbon 2 and the hydroxyls at carbons 3 and 6. NMR-data of BPA-F indicates that the β-D-fructofuranose 2,3,6-(p-phenylalanylorthoboronate) structure strongly predominates. 8) In the preparation of BPA-F compound for the clinical trials 99% pure L-p-boronophenylalanine is used as an active pharmaceutical ingredient. The maximum sum of all impurities (HPLC) is 1.0%. The specification for the assay of L-p-boronophenylalanine is 98.0-102.0% based on dry substance and any individual impurity (HPLC) maximum is 0.5%. The bacterial endotoxins (LAL test) maximum is 0.05 EU/mg.
At present, the six hours shelf life of BPA-F after preparation causes major difficulties in practice. Preparation in one site, transportation to the microbiological laboratory for LAL test and further to the clinic for actual treatment must be accomplished within the shelf life. Occasionally patients are too weak to be treated and the expensive drug has to be Till date, pharmaceutical and chemical stability of the BPA-F complex has not been evaluated as a function of time. In a previous study, stability of the BPA-F complex was studied using a liquid chromatographic method (HPLC), and as a result, the complex was reported to remain stable for 12 days.
9)

MATERIALS AND METHODS
Samples
The studied samples were taken from three separate BPA-F batches manufactured for the BNCT patients. The samples were packed in 7 ml vials and closed with the depyrogenated rubber caps and aluminium seals. The samples were stored in the labelled paperboard boxes at room temperature. For NMR measurements the volume of 550 μl of neat BPA-F infusion solution was transferred into a 5 mm outer diameter NMR sample tube (Wilmad 507-PP-7). A 2 mm outer diameter coaxial insert (Wilmad WGS-5BL) containing external reference compound, 40 mM TSP-d4 (trimethylsilyl-2,2,3,3-tetradeuteropropionic acid) in D2O, was inserted into the NMR tube. Methyl proton signal of TSP-d4 was used as intensity reference as well as for referencing the chemical shift scale. The D2O in coaxial insert served as lock substance.
Test of sterility
The sterility testing of pharmaceutical preparations is commonly applied when the preparation is required to be sterile. In this study, the sterility test was carried out according to European Pharmacopoeia.
10) The test facilities were designed for the purpose and were under suitable conditions. Fluid thioglycollate medium (TGM), which is mainly intended for the culture of anaerobic bacteria, but supports also aerobic growth, and Soya-bean casein digest medium (SBCM), which supports both fungi and aerobic bacteria were used as culture media.
Growth promotion test of aerobes, anaerobes and fungi: TGM was tested by inoculating a small number (not more than 100 CFU) of Staphylococcus aureus, Bacillus subtilis, Pseudomonas aeruginosa and Clostridium sporogenes in separate portions of medium and incubating it at 30-35°C for 3 days. SBCM was tested by using Candida albicans and Aspergillus niger microbes and incubating at 20-25°C for 5 days. Each sample was inoculated as duplicates for both culture media. The vials were incubated for 14 days.
Validation test, direct inoculation: BPA-F complex is an old product and the validation test for antimicrobial activity has been performed earlier with Staphylococcus aureus, Bacillus subtilis and Candida albicans using the direct inoculation method. The stability studies have not been revalidated. No antimicrobial activity has observed in BPA-F -compound.
Test for sterility of the BPA-F: Each BPA-F sample of 1 ml was inoculated into the media (TGM and SBCM) vials. The inoculated media were incubated for 14 days, at 30-35°C (TGM vials) or at 20-25°C (SBCM vials).
Bacterial endotoxins
The bacterial endotoxin test was used to detect endotoxin level of the product. The Limulus amebocyte lysate (LAL) test was applied, which is based on a biological enzyme reaction detecting endotoxin of gram-negative bacterial origin by using amoebocyte lysate from horseshoe crab. The gel-clot limit test method A was applied according to European Pharmacopoeia.
11) The confirmation of the labelled lysate sensitivity and the interfering factors were tested.
Limit test: Solutions A, B, C and D were prepared and diluted.
Solution A The BPA-F compound test solution. No added endotoxin. Solution B Positive product control. BPA-F compound with endotoxin amount two fold compared to lysate sensitivity added. Solution C Positive control. LAL-water with endotoxin amount two fold compared to lysate sensitivity added. Solution D Negative control. Endotoxin free LAL-water. Shortly, the samples, dilutions and controls were applied into the pyrogen-free test tubes and then 30 μl of lysate (sensitivity 0.03 U/ml) was added. The tubes were covered and shaken manually and incubated in water bath at 37°C for 60 minutes. The test tubes were directly removed from the incubator, inverted 180° upside down with one smooth motion. The formation of solid gel confirms presence of the endotoxin in sample.
Clarity and degree of opalescence
Visual method: The colourless, transparent, neutral glass test-tubes were used the visual examinations. The BPA-F solution was compared with the freshly prepared reference suspension.
12) The layer depth was approximately 40 mm. The samples were viewed vertically against a black background and compared with the reference suspension I and suspension II, and water.
Degree of coloration
The BPA-F solution coloration was studied using the method II of European Pharmacopeia.
13) The coloration degree was examined using colourless, transparent, neutral glass tubes and 5 colour standards. The colour standards were diluted with hydrochlorid acid into seven degrees of reference colours: brown, brownish-yellow, yellow, greenish-yellow and red. BPA-F was compared vertically against the reference colours using a white background.
Biological test time points
The preparation day of the batch was set as day 0 and day 11 means the duration of the study for each batch ( Table 1) . The studies were done for each of the three batches.
Structural stability tests
1 H NMR signal pattern of BPA aromatic protons consists of two doublets.
14) The aromatic region in 1 H NMR spectrum of BPA-F sample contains three sets of aforementioned signals with significant intensity (Fig. 1, Figs. EA1-EA2 in Electronic appendix). These originate from three different forms of BPA (the most intense doublets arise from the desired BPA-F complex while smaller ones come from free BPA and from different complex form/complex intermediate), 15, 16) which are in continuous exchange ( To investigate the structural stability of the BPA-F complex, 1 H NMR measurements were performed at certain time points during 11 day test period (see: Electronic appendix for details). The intensity of BPA-F doublet signal at 7.45 ppm was chosen for the study (integral region 7.389-7.483 ppm) since according to 2D COSY experiment (Fig. EA2 in Electronic appendix) superficially well separated BPA-Fsignal at 7.15 ppm is overlapping with signal arising from other complex form/complex intermediate. The methyl proton signal of TSP-d4 at 0 ppm was integrated (integral region -0.034-0.031 ppm) and the intensity was used as reference. The relative intensities were calculated i.e. ratio of aromatic proton intensity to the intensity of the reference compound. This procedure ensures that possible fluctuation in instrument performance in course of time does not affect the result. If the relative intensity of the aromatic protons of BPA-F sample is ≥ 90% of the initial relative intensity, the infusion solution can be considered usable from the structural point of view since it can be expected that the ≥ 90% of BPA-F molecules in the infusion solution still have the desired original complex structure. In this structural stability study, we have concentrated in evaluating the time span after which sufficient percentage of the initial intensity corresponding the original structure remains in the infusion liquid. No attempts were made to characterize actual molecular structures but instead it is assumed that peak pattern at 7.45 ppm in the freshly made solution correspond to the desired complex structure and possible intensity changes reflect the changes in the complex structure.
Detailed measurement and processing parameters for NMR experiments, complete 1 H NMR spectrum of fresh BPA-F sample, 2D COSY spectrum as well as expansion of 2D NOESY spectrum are presented in Electronic appendix.
Find http://www.jstage.jst.go.jp/browse/jrr/
RESULTS AND DISCUSSION
The results for biological tests and the results from structural stability study are summarized in Table 2 and Fig. 2 , respectively. These results suggest that BPA-F remains stable within the time period studied.
Sterility: The sterility of the BPA-F compound was studied at all four time points. No growth of micro-organisms was detected indicating that the product was sterile.
Bacterial endotoxins: Bacterial endotoxins were tested in the beginning of and after the stability studies. All test results were negative indicating that the product was free of endotoxins.
Clarity and degree of opalescence: Clarity was studied at every time point. BPA-F compound remained clear during the 11 days study.
Degree of coloration: Slight changes were observed in coloration between the batches during the storage. The highest degree of yellow coloration was found to be between Y5-Y6 in one batch, the range being: Y1 the strongest colour and Y7 the weakest, next to colourless. The colour change was not significant.
Structural stability: Ratio of BPA-F intensity to the intensity of methyl signal of reference compound, TSP-d4 as a function of storage time for three batches is presented in Fig.  2 . The first data point of each batch was set to 100%. Figure  2 clearly shows that BPA-F infusion solution in each batch contains > 90% of original complex structure after 11 days. In fact, the intensity is > 99% of the original value. This allows us to assume, that the original complex structure of Table 1 . Biological tests conducted in time points.
Time Day 0 Day 4 Day 7 Day 11
Bacterial endotoxins X --X Sterility X X X X Clarity and degree of opalescence X X X X Degree of coloration X X X X To summarize the results, the biological properties of the BPA-F solutions as well as chemical structure of the BPA-F complex remained the same during the test period. Visually the solutions remained clear but there was a slight change in colour which is caused by the interaction between amino acids and fructose commonly known as the Maillard reaction. According to the obtained results, the BPA-F complex is stable for at least 11 days after preparation and the shelf life could be extended accordingly. 
